Novoray Corporation Logo

Novoray Corporation

688300.SS

(3.5)
Stock Price

51,40 CNY

12.3% ROA

16.13% ROE

49.46x PER

Market Cap.

10.804.844.820,00 CNY

13.32% DER

0.86% Yield

26.14% NPM

Novoray Corporation Stock Analysis

Novoray Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Novoray Corporation Fundamental Stock Analysis
# Analysis Rating
1 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

2 DER

The stock has a low debt to equity ratio (6%), which means it has a small amount of debt compared to the ownership it holds

3 Revenue Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

4 Net Profit Growth

Over the last five years, this company's net profit has shown continuous growth, reflecting a robust financial performance and making it an attractive choice for potential investors.

5 Assets Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

6 ROE

The stock's ROE falls within an average range (14.45%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

7 Dividend Growth

The company's dividend growth has exhibited a remarkable upward trend over the past three years, consistently delivering higher payouts to shareholders.

8 Dividend

The company's track record of consistently paying dividends in the last three years highlights its dedication to providing investors with regular income.

9 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (266), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

10 PBV

The stock's high Price-to-Book Value (P/BV) ratio (7.33x) suggests it's overvalued, potentially making it an expensive investment.

11 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

Novoray Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Novoray Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Novoray Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Novoray Corporation Revenue
Year Revenue Growth
2012 108.534.666
2013 120.498.554 9.93%
2014 125.327.219 3.85%
2015 122.361.649 -2.42%
2016 153.632.695 20.35%
2017 210.960.245 27.17%
2018 278.106.010 24.14%
2019 315.301.090 11.8%
2020 404.203.405 21.99%
2021 624.709.594 35.3%
2022 661.954.238 5.63%
2023 786.985.167 15.89%
2023 704.182.819 -11.76%
2024 956.653.764 26.39%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Novoray Corporation Research and Development Expenses
Year Research and Development Expenses Growth
2012 6.708.404
2013 0 0%
2014 0 0%
2015 0 0%
2016 7.125.326 100%
2017 8.273.222 13.87%
2018 10.555.540 21.62%
2019 12.832.975 17.75%
2020 19.784.132 35.14%
2021 35.056.247 43.56%
2022 38.498.866 8.94%
2023 54.385.817 29.21%
2023 47.404.042 -14.73%
2024 64.895.408 26.95%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Novoray Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 18.855.974
2013 20.896.301 9.76%
2014 20.045.816 -4.24%
2015 18.080.101 -10.87%
2016 11.269.788 -60.43%
2017 15.320.544 26.44%
2018 3.540.951 -332.67%
2019 8.014.901 55.82%
2020 5.926.269 -35.24%
2021 7.282.983 18.63%
2022 8.446.203 13.77%
2023 133.766.079 93.69%
2023 12.120.057 -1003.68%
2024 -32.059.979 137.8%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Novoray Corporation EBITDA
Year EBITDA Growth
2012 22.309.968
2013 23.145.007 3.61%
2014 26.496.281 12.65%
2015 26.819.692 1.21%
2016 47.583.311 43.64%
2017 56.570.279 15.89%
2018 81.243.404 30.37%
2019 101.712.356 20.12%
2020 151.710.649 32.96%
2021 219.406.784 30.85%
2022 227.941.150 3.74%
2023 236.625.218 3.67%
2023 217.125.240 -8.98%
2024 320.361.400 32.22%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Novoray Corporation Gross Profit
Year Gross Profit Growth
2012 42.946.711
2013 46.842.959 8.32%
2014 51.664.855 9.33%
2015 50.760.364 -1.78%
2016 65.318.655 22.29%
2017 87.049.745 24.96%
2018 119.217.928 26.98%
2019 146.012.842 18.35%
2020 173.159.498 15.68%
2021 265.263.549 34.72%
2022 259.469.731 -2.23%
2023 336.651.065 22.93%
2023 264.932.064 -27.07%
2024 392.240.328 32.46%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Novoray Corporation Net Profit
Year Net Profit Growth
2012 14.018.951
2013 14.239.832 1.55%
2014 18.906.255 24.68%
2015 18.219.460 -3.77%
2016 32.708.951 44.3%
2017 42.248.863 22.58%
2018 58.366.455 27.61%
2019 74.694.979 21.86%
2020 110.916.230 32.66%
2021 172.867.734 35.84%
2022 188.240.500 8.17%
2023 207.183.140 9.14%
2023 173.994.421 -19.07%
2024 263.247.244 33.9%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Novoray Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 1 0%
2021 1 0%
2022 1 100%
2023 1 0%
2023 1 0%
2024 1 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Novoray Corporation Free Cashflow
Year Free Cashflow Growth
2012 -14.796.477
2013 21.212.596 169.75%
2014 14.736.080 -43.95%
2015 -575.876 2658.9%
2016 15.415.845 103.74%
2017 -19.807.180 177.83%
2018 30.401.688 165.15%
2019 20.232.677 -50.26%
2020 -34.447.705 158.73%
2021 -54.547.019 36.85%
2022 85.859.655 163.53%
2023 203.773.002 57.87%
2023 944.017 -21485.76%
2024 90.264.088 98.95%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Novoray Corporation Operating Cashflow
Year Operating Cashflow Growth
2012 16.164.484
2013 27.797.319 41.85%
2014 17.334.100 -60.36%
2015 7.419.400 -133.63%
2016 23.170.827 67.98%
2017 6.497.142 -256.63%
2018 55.685.280 88.33%
2019 80.576.233 30.89%
2020 89.686.223 10.16%
2021 153.423.336 41.54%
2022 240.677.481 36.25%
2023 256.789.740 6.27%
2023 14.162.253 -1713.2%
2024 119.819.095 88.18%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Novoray Corporation Capital Expenditure
Year Capital Expenditure Growth
2012 30.960.961
2013 6.584.722 -370.19%
2014 2.598.020 -153.45%
2015 7.995.276 67.51%
2016 7.754.982 -3.1%
2017 26.304.322 70.52%
2018 25.283.592 -4.04%
2019 60.343.556 58.1%
2020 124.133.928 51.39%
2021 207.970.355 40.31%
2022 154.817.826 -34.33%
2023 53.016.738 -192.02%
2023 13.218.236 -301.09%
2024 29.555.007 55.28%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Novoray Corporation Equity
Year Equity Growth
2012 123.016.856
2013 77.256.688 -59.23%
2014 96.162.944 19.66%
2015 123.332.404 22.03%
2016 162.728.344 24.21%
2017 192.981.208 15.68%
2018 319.545.061 39.61%
2019 896.148.961 64.34%
2020 963.947.587 7.03%
2021 1.093.709.453 11.86%
2022 1.230.031.593 11.08%
2023 1.297.936.827 5.23%
2023 1.347.439.223 3.67%
2024 1.373.720.004 1.91%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Novoray Corporation Assets
Year Assets Growth
2012 168.792.910
2013 190.022.079 11.17%
2014 177.216.292 -7.23%
2015 196.087.559 9.62%
2016 244.178.920 19.7%
2017 303.090.735 19.44%
2018 413.731.136 26.74%
2019 1.023.726.519 59.59%
2020 1.092.568.726 6.3%
2021 1.304.902.145 16.27%
2022 1.537.623.162 15.14%
2023 1.657.471.090 7.23%
2023 1.754.701.349 5.54%
2024 1.827.224.069 3.97%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Novoray Corporation Liabilities
Year Liabilities Growth
2012 45.776.053
2013 112.765.390 59.41%
2014 81.053.348 -39.12%
2015 72.755.155 -11.41%
2016 81.450.575 10.68%
2017 110.109.527 26.03%
2018 94.186.075 -16.91%
2019 127.577.557 26.17%
2020 128.621.138 0.81%
2021 211.192.692 39.1%
2022 307.591.569 31.34%
2023 359.534.263 14.45%
2023 317.691.365 -13.17%
2024 367.559.890 13.57%

Novoray Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
4.5
Net Income per Share
1.18
Price to Earning Ratio
49.46x
Price To Sales Ratio
12.93x
POCF Ratio
44.33
PFCF Ratio
63.07
Price to Book Ratio
7.87
EV to Sales
12.85
EV Over EBITDA
41.47
EV to Operating CashFlow
44.05
EV to FreeCashFlow
62.68
Earnings Yield
0.02
FreeCashFlow Yield
0.02
Market Cap
10,80 Bil.
Enterprise Value
10,74 Bil.
Graham Number
13.99
Graham NetNet
2.61

Income Statement Metrics

Net Income per Share
1.18
Income Quality
1.12
ROE
0.16
Return On Assets
0.12
Return On Capital Employed
0.15
Net Income per EBT
0.88
EBT Per Ebit
1.11
Ebit per Revenue
0.27
Effective Tax Rate
0.12

Margins

Sales, General, & Administrative to Revenue
0.02
Research & Developement to Revenue
0.07
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.4
Operating Profit Margin
0.27
Pretax Profit Margin
0.3
Net Profit Margin
0.26

Dividends

Dividend Yield
0.01
Dividend Yield %
0.86
Payout Ratio
0.69
Dividend Per Share
0.5

Operating Metrics

Operating Cashflow per Share
1.31
Free CashFlow per Share
0.92
Capex to Operating CashFlow
0.3
Capex to Revenue
0.09
Capex to Depreciation
5.34
Return on Invested Capital
0.13
Return on Tangible Assets
0.12
Days Sales Outstanding
144.86
Days Payables Outstanding
81.84
Days of Inventory on Hand
73.25
Receivables Turnover
2.52
Payables Turnover
4.46
Inventory Turnover
4.98
Capex per Share
0.39

Balance Sheet

Cash per Share
2,98
Book Value per Share
7,86
Tangible Book Value per Share
7.58
Shareholders Equity per Share
7.4
Interest Debt per Share
1
Debt to Equity
0.13
Debt to Assets
0.1
Net Debt to EBITDA
-0.26
Current Ratio
3.28
Tangible Asset Value
1,41 Bil.
Net Current Asset Value
0,62 Bil.
Invested Capital
1344574339
Working Capital
0,69 Bil.
Intangibles to Total Assets
0.03
Average Receivables
0,34 Bil.
Average Payables
0,09 Bil.
Average Inventory
99272362.5
Debt to Market Cap
0.02

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Novoray Corporation Dividends
Year Dividends Growth
2020 1
2021 1 0%
2022 1 0%
2023 1 0%
2024 1 0%

Novoray Corporation Profile

About Novoray Corporation

Novoray Corporation researches, develops, manufactures, and sells industrial powder materials for various applications worldwide. The company offers crystalline silica powder, fused silica powder, soft composite silica powder, round corner crystalline silica powder, spherical silica powder, spherical aluminum oxide powder, sub-micron spherical silica powder, and acicular powder. It serves electronic materials, electrical insulating materials, ceramics, precision casting, paints and coatings, silicon rubber, functional rubber, plastics, and building materials manufacturing industries worldwide. Novoray Corporation was founded in 1984 and is based in Lianyungang, China.

CEO
Mr. Xiaodong Li
Employee
569
Address
No.6, Zhujiang Road
Lianyungang, 222346

Novoray Corporation Executives & BODs

Novoray Corporation Executives & BODs
# Name Age
1 Mr. Xiaodong Li
Chairman & GM
70
2 Mr. Songzhou Wang
Chief Financial Officer & Deputy GM
70
3 Mr. Jiakai Cao
Deputy GM & Director
70
4 Ms. Lin Bo
Secretary
70
5 Mr. Jian Ping Zhang
Director of Technology Center & Core Technician
70

Novoray Corporation Competitors